Abstract:Objective To explore the efficacy difference of diffusion kurtosis imaging (DKI) and ultrasound elastography (UE) in the diagnosis of liver fibrosis. Methods Thirty-five patients whose serological examination showed hepatitis B or hepatitis C virus infection, disease course≥ 1 year, and finally liver biopsy confirmed pathological fibrosis grade in Tianjin Second People's Hospital from December 2015 to April 2017 were prospectively enrolled as patient group. During the same period, twenty healthy volunteers who matched the age, sex and BMI with patient group and showed normal liver function within the last month were enrolled as control group. All of the subjects underwent DKI experiment, and subjects in patient group underwent UE experiment in addition. Liver mean apparent diffusion (MD) and mean kurtosis (MK) were obtained in all subjects and liver stiffness measurement (LSM) was obtained in patient group. The patient group was staged for hepatic fibrosis based on liver biopsy results (S0 to S4). Differences in liver MD and MK values between control and patient groups were tested using independent sample t test (normal distribution) or Mann-Whitney U test (skewed distribution). Differences in liver MD, MK, and LSM between patients with different fibrosis stages were tested using One-way ANOVA (normal distribution) or Kruskal-Wallis test (skewed distribution). The correlation between liver MD, MK and LSM values with fibrosis stages were analyzed using Pearson correlation test. The diagnostic performance in staging fibrosis was analyzed using ROC analysis. Results Liver MD in patient group was lower than that in control group, and the difference was statistically significant (P<0.01). There was no significant difference in liver MK between the two groups (P>0.05). The AUC value for the diagnosis of liver fibrosis by MD was 0.950 (95％CI:0.855 to 0.990). Of the 35 patients, 15 were S1 (mild fibrosis), 13 were S2 (moderate fibrosis), 4 were S3, 3 were S4 (S3+S4 were severe fibrosis). The difference of MD and LSM between different stages of liver fibrosis was statistically significant (P<0.05), and there was no significant difference in MK (P>0.05). Liver fibrosis stages was highly correlated with MD (r=-0.757, P<0.01), and had no correlation with MK (r=-0.010, P=0.956), and moderately correlated with LSM (r=0.440, P<0.01). The AUC values of liver MD and LSM for characterization of ≥S2 stage liver fibrosis were 0.867 and 0.800, respectively, without statistically significant difference (P=0.486). The AUC values for characterization of≥S3 stage liver fibrosis were 0.918 and 0.653, respectively, with a statistically significant difference (P=0.032). Conclusion MD derived from DKI can be used for noninvasive assessment of liver fibrosis, and it is superior to LSM in distinguishing different fibrosis stages and detecting severe fibrosis.

Diffusion kurtosis imaging for assessing endometrial fibrosis: a preliminary clinical study

Initial Experience with Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Endometrial Fibrosis.

Noninvasive assessment of endometrial fibrosis in patients with intravoxel incoherent motion MR imaging

Comparative analysis of the value of diffusion kurtosis imaging and diffusion-weighted imaging in evaluating the histological features of endometrial cancer

Quantitative Evaluation of Diffusion-Kurtosis Imaging for Grading Endometrial Carcinoma: a Comparative Study with Diffusion-Weighted Imaging.

Diffusion kurtosis imaging for the assessment of renal fibrosis of chronic kidney disease: A preliminary study

Renal Functional and Interstitial Fibrotic Assessment with Non-Gaussian Diffusion Kurtosis Imaging

Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.

Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules

MR Diffusion Kurtosis Imaging for Cancer Diagnosis: A Meta-Analysis of the Diagnostic Accuracy of Quantitative Kurtosis Value and Diffusion Coefficient.

MR Diffusion Kurtosis Imaging (DKI) of the Normal Human Uterus in Vivo During the Menstrual Cycle

The Role of Diffusion Kurtosis MR Imaging in the Evaluation of Invasive Breast Cancer Classification and Its Correlation with Prognostic Factors: A Prospective Study of Primarily Advanced Stage Cancers

Diffusion Kurtosis Imaging in Assessment of Gastric Cancer Aggressiveness

Diffusion kurtosis imaging as an imaging biomarker for predicting prognosis in chronic kidney disease patients

Preliminary Feasibility Study on Diffusion Kurtosis Imaging to Monitor the Early Functional Alterations of Kidneys in Streptozocin-Induced Diabetic Rats

Diagnostic Value of Diffusion Kurtosis Imaging in Assessing Liver Fibrosis

Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes

The study of diffusion kurtosis imaging value for assessing liver fibrosis and comparison with ultrasound elastography

Diffusion kurtosis imaging evaluating epithelial–mesenchymal transition in colorectal carcinoma xenografts model: a preliminary study

Preoperative identification of cytokeratin 19 status of hepatocellular carcinoma based on diffusion kurtosis imaging

Quantification of Endometrial Fibrosis Using Noninvasive MRI T2 Mapping: Initial Findings